MedTrace Logo

Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma.

NCT07280234 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 218

Last updated 2025-12-12

No results posted yet for this study

Summary

In this study we compared the effect of intradermal microinjections of tranexamic acid vs oral tranexamic acid in treatment of melasma. Given the high prevalence of melasma in Pakistan and the significant psychosocial impact on patients, particularly in Peshawar, this study will provide valuable insights into optimal treatment strategies

Conditions

  • Melasma

Interventions

DRUG

Intradermal microinjections of tranexamic acid

This group A will recieve intradermal microinjections of tranexamic acid

DRUG

Oral tranexamic acid

This group B will recieve oral tranexamic acid

Sponsors & Collaborators

  • Hayat Abad Medical Complex, Peshawar

    lead OTHER_GOV

Principal Investigators

  • Ghafoor Ullah Ullah, FCPS part 2 · MTI-HMC Peshawar, Peshawar Khyber PakhtunKhwa 25000

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-14
Primary Completion
2025-05-15
Completion
2025-05-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07280234 on ClinicalTrials.gov